A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Recruiting now · Phase 1/Phase 2

Conditions studied: Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary, Squamous Non-small-cell Lung Cancer, Triple Negative Breast Cancer, Head and Neck Squamous Cell Carcinoma, Ovarian Carcinosarcoma, Uterine Carcinosarcoma, Uterine Serous Carcinoma, Endometrium Cancer, Chromosomal Instability

In brief

This is a first-in-human phase I/II study to examine the safety, tolerability and preliminary efficacy of VLS-1488 in subjects with advanced cancers.

Key facts

Study ID
NCT05902988
Run by
Volastra Therapeutics, Inc.
People needed
200
Starts
2023-10-18
Expected to finish
2026-12-01
Last updated by the study team
2025-11-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.